Product ID:ARISTO-PAK TABLETS
MSDS Date:01/01/1994
FSC:6505
NIIN:00F036225
MSDS Number: BTVMT

FUJISAWA USA INC (LYPHOMED INC)

3 PARKWAY NORTH
DEERFIELD, IL 60015-2548
US

Emergency Phone: 708-317-8202

Info Phone: 800-727-7003/708-317-8800

Preparer: CHRISTINA J BARRINGTON

Cage: 24832

FUJISAWA USA, INC

DEERFIELD, IL 60015-2548 US

Telephone: 847-317-1256

Cage: 39832

DRIED CORNSTARCH

DICALCIUM PHOSPHATE *94-2*

CAS: 7757-93-9

DIOCTYL SODIUM SULFOSUCCINATE

CAS: 577-11-7

RTECS: WN0525000

LACTOSE

CAS: 63-42-3

RTECS: OD9625000

MAGNESIUM STEARATE

CAS: 557-04-0

RTECS: WI4390000

CELLULOSE

CAS: 9004-34-6

RTECS: FJ5691460

OSHA PEL 5 MG/CUM

ACGIH TLV: 10 MG/CUM (DUST)

RED 30

SODIUM BENZOATE

CAS: 532-32-1

RTECS: DH6650000

SODIUM STARCH GLYCOLATE

TRIAMCINOLONE

CAS: 124-94-7

RTECS: TU3850000

D&C YELLOW NO. 10

Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:IMMEDIATE EFFECTS: IRRITATION OF
SKIN/EYES. DELAYED EFFECTS: PRIMARY IRRITATION OF SKIN/EYES,
HEADACHE, MUSCULAR WEAKNESS, CONVULSIONS,FLUID RETENTION.
Explanation of Carcinogenicity:NONE
Effects of Overexposure:IMMEDIATE EFFECTS: IRRITATION OF SKIN/EYES.
DELAYED EFFECTS: PRIMARY IRRITATION OF SKIN/EYES, HEADACHE,
MUSCULAR WEAKNESS, CONVULSIONS, FLUID RETENTION.
Medical Cond Aggravated by Exposure:PRE-EXISTING SKIN CONDITIONS.

First Aid:INHALATION: MOVE TO FRESH AIR. GIVE CPR IF REQUIRED.
INGESTION: FLUSH MOUTH OUT W/WATER IMMEDIATELY. SKIN: FLUSH AREA
W/WATER FOR 15 MINS. EYES: IMMEDIATELY FLUSH W/WATER FOR 15 MINS.
OBTAIN MEDICAL A TTENTION IN ALL CASES.

Flash Point Method:CC
Flash Point:(SEE SUPP)
Extinguishing Media:WATER SPRAY, DRY CHEMICAL, CO2, FOAM.
Fire Fighting Procedures:WEAR SELF-CONTAINED BREATHING APPARATUS &
PROTECTIVE CLOTHING.

Spill Release Procedures:WEAR RECOMMENDED PERSONAL PROTECTIVE
EQUIPMENT. USE ABSORBENT TOWELS/BOOMS TO CLEAN UP. WIPE SURFACES
CLEAN/WASH W/SOAP & WATER.

Handling and Storage Precautions:WHEN HANDLING PHARMACEUTICAL PRODUCTS,
AVOID CONTACT/INHALATION OF DUST, FUMES, MIST/VAPORS ASSOCIATED
W/PRODUCT.

Respiratory Protection:NOT USUALLY REQUIRED W/SATISFACTORY VENTILATION.
Ventilation:GENERAL ROOM. LOCAL EXHAUST WHEN NECESSARY.
Protective Gloves:DISPOSABLE LATEX
Eye Protection:SAFETY GLASSES/GOGGLES
Other Protective Equipment:DISPOSABLE GARMENTS
Work Hygienic Practices:REMOVE/LAUNDER CONTAMINATED CLOTHING BEFORE
REUSE.
Supplemental Safety and Health
FLASH POINT: COMBUSTIBLE POWDER. THIS PRODUCT IS INTENDED FOR
THERAPEUTIC USE ONLY WHEN PRESCRIBED BY A PHYSICIAN.

Appearance and Odor:TABLETS, OBLONG, FLAT & SCORED

Stability Indicator/Materials to Avoid:YES
NONE
Stability Condition to Avoid:NONE
Hazardous Decomposition Products:SMOKE & FLUORINE FUMES

Waste Disposal Methods:DISPOSE OF IAW/FEDERAL, STATE & LOCAL
REGULATIONS.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.